BLAZE BIOSCIENCE, INC.

Profile

Company Names

BLAZE BIOSCIENCE, INC.

Addresses

530 FAIRVIEW AVENUE N., SUITE 1400, SEATTLE, WA 98109

530 FAIRVIEW AVENUE N., SUITE 100, SEATTLE, WA 98109

530 FAIRVIEW AVE N., SUITE 1000, SEATTLE, WA 98109

Phone Numbers

2065358144
2068493647

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2010

State Incorporated:

DELAWARE

Total Amount Raised:

$115,758,374.00

Number of Funding Rounds:

12
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
12
2024-02-15 
$8,060,000.00 
$20,000,000.00 
$11,940,000.00 
Debt 
11
2022-10-06 
$25,000,000.00 
$25,000,000.00 
$0.00 
Debt 
10
2021-10-07 
$15,000,000.00 
$15,000,000.00 
$0.00 
Debt 
9
2020-10-30 
$10,000,000.00 
$10,000,000.00 
$0.00 
Debt 
8
2019-02-01 
$20,230,000.00 
$25,237,759.00 
$5,007,759.00 
Equity 
7
2018-05-10 
$3,000,000.00 
$5,000,000.00 
$2,000,000.00 
Debt 
6
2017-10-03 
$16,108,197.00 
$18,105,620.00 
$1,997,423.00 
Equity 
5
2017-06-08 
$554,000.00 
$5,000,000.00 
$4,446,000.00 
Debt 
4
2015-12-31 
$991,000.00 
$4,990,000.00 
$3,999,000.00 
Debt 
3
2013-06-14 
$9,711,998.00 
$15,000,000.00 
$5,288,002.00 
Equity 
2
2012-06-06 
$6,378,179.00 
$10,721,462.00 
$4,343,283.00 
Equity 
1
2011-10-03 
$725,000.00 
$1,500,000.00 
$775,000.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
STEVEN 
R. 
DALY 
EXECUTIVE OFFICER, DIRECTOR
HEATHER 
 
FRANKLIN 
EXECUTIVE OFFICER, DIRECTOR
HEATHER 
L. 
FRANKLIN 
DIRECTOR
LAWRENCE 
PATRICK 
HUGHES 
DIRECTOR
MARY 
ELLEN 
HUGHES 
DIRECTOR
CLAUDIA 
 
JOCHHEIM 
EXECUTIVE OFFICER
LUDMILA 
 
LOBANOVA 
EXECUTIVE OFFICER
LUDMILA 
R. 
LOBANOVA 
EXECUTIVE OFFICER
DENNIS 
MILLER 
EXECUTIVE OFFICER
JULIA 
 
NOVAK 
EXECUTIVE OFFICER
JAN 
 
OHRSTROM 
DIRECTOR
JAN 
K. 
OHRSTROM 
DIRECTOR
JAN 
KOCH 
OHRSTROM 
DIRECTOR
JAMES 
 
OLSON 
DIRECTOR
JAMES 
M. 
OLSON 
DIRECTOR
JAMES 
 
TOWNE 
DIRECTOR
JAMES 
C. 
TOWNE 
DIRECTOR, EXECUTIVE OFFICER
JAMES 
CAMERON 
TOWNE 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2022-10-06 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2024-02-15 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2020-10-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2021-10-07 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-02-01 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-02-01 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-05-10 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-10-03 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-06-08 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2015-12-31 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-06-14 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-06-14 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-06-14 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-06-06 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-10-03 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#